Q · Qnity Electronics, Inc. · Earnings Call Transcripts & Audio
Market Cap
$26.25B
Shares
209.21M
Qnity Electronics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Qnity Electronics, Inc. (Q), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q2
2026-08-04
Qnity Electronics, Inc. (Q) Q2 2026 Earnings Call Transcript
Confident tone
Capital investment and capacity expansion
Shrink-to-stack semiconductor trend
Advanced packaging and interconnects
Revenue
$1.43B
▲ 22.1% YoY Diluted EPS
$0.59
▼ 34.4% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Qnity Electronics, Inc. (Q) Q1 2026 Earnings Call Transcript
Confident tone
Interconnect Solutions segment performance
AI-driven growth and advanced packaging
Financial results and guidance
Revenue
$1.31B
▲ 17.6% YoY Diluted EPS
$0.72
▼ 21.7% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Qnity Electronics, Inc. (Q) Q4 2025 Earnings Call
Confident tone
Advanced packaging growth
End market diversification
AI and advanced node demand
Revenue
$1.19B*
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Qnity Electronics, Inc. (Q) Q3 2025 Earnings Call Transcript
Confident tone
Third quarter financial performance
AI-driven semiconductor demand
Spin-off launch and stand-alone operations
Revenue
$1.28B
▲ 11.1% YoY Diluted EPS
$1.01
▲ 6.3% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Qnity Electronics, Inc. (Q) Q2 2025 Earnings Call Transcript
Positive tone
Quarterly financial results
TAS business activity and wins
R&D Solutions bookings and pipeline
Revenue
$1.17B
Diluted EPS
$0.90
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Qnity Electronics, Inc. (Q) Q1 2025 Earnings Call Transcript
Positive tone
Margin mix and restructuring
TAS commercial recovery
R&DS clinical demand softness
Revenue
$1.12B
Diluted EPS
$0.92
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls
Key facts
CIK
2058873
CUSIP
74743L100
13F (30d)
530 filings
523 filers
Visit website
Investor relations